Editorial: Debates in experimental pharmacology and drug discovery 2023: innovative approaches to chronic kidney disease drug discovery, identification of targets and safety assessment.
作者信息
Khan Md Abdul Hye, Ameer Omar Z, Goorani Samaneh, Salman Ibrahim M
机构信息
Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Department of Pharmaceutical Sciences, College of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
出版信息
Front Pharmacol. 2025 Mar 25;16:1588367. doi: 10.3389/fphar.2025.1588367. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Debates in experimental pharmacology and drug discovery 2023: innovative approaches to chronic kidney disease drug discovery, identification of targets and safety assessment.社论：2023年实验药理学与药物发现中的辩论：慢性肾病药物发现、靶点识别与安全性评估的创新方法
Front Pharmacol. 2025 Mar 25;16:1588367. doi: 10.3389/fphar.2025.1588367. eCollection 2025.
2
2011 Annual Meeting of the Safety Pharmacology Society: an overview.2011 年安全药理学学会年会：概述。
Expert Opin Drug Saf. 2012 Mar;11(2):341-53. doi: 10.1517/14740338.2012.661412. Epub 2012 Feb 18.
3
Relevance of systems pharmacology in drug discovery.系统药理学在药物发现中的相关性。
Drug Discov Today. 2012 Jul;17(13-14):665-70. doi: 10.1016/j.drudis.2012.01.015. Epub 2012 Jan 25.
4
Editorial: Commercialization and industrialization in experimental pharmacology and drug discovery: 2023.社论：实验药理学与药物发现中的商业化与产业化：2023年
Front Pharmacol. 2024 Dec 11;15:1528987. doi: 10.3389/fphar.2024.1528987. eCollection 2024.
5
Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.基于网络药理学的研究与实验验证预测肾康注射液治疗慢性肾脏病的作用机制。
J Ethnopharmacol. 2020 Jan 10;246:112128. doi: 10.1016/j.jep.2019.112128. Epub 2019 Aug 3.
6
Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022.社论：心血管药理学与药物研发辩论：2022年
Front Cardiovasc Med. 2023 Oct 18;10:1304680. doi: 10.3389/fcvm.2023.1304680. eCollection 2023.
7
Drug Repositioning Through Network Pharmacology.基于网络药理学的药物重新定位
Curr Top Med Chem. 2016;16(30):3646-3656. doi: 10.2174/1568026616666160530181328.
8
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.系统药理学时代基于生物标志物的药物安全性评估：从基础科学到监管科学
Biomark Med. 2015;9(11):1241-52. doi: 10.2217/bmm.15.81. Epub 2015 Oct 28.
9
High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery.用于转化药物发现的周转、激活和抑制的高性能酶动力学
Expert Opin Drug Discov. 2017 Jan;12(1):17-37. doi: 10.1080/17460441.2017.1245721. Epub 2016 Nov 3.
10
Identification of drug candidates and repurposing opportunities through compound-target interaction networks.通过化合物-靶标相互作用网络鉴定药物候选物和再利用机会。
Expert Opin Drug Discov. 2015 Dec;10(12):1333-45. doi: 10.1517/17460441.2015.1096926. Epub 2015 Oct 1.
Zotero 插件